Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Acoustically-stimulated microbubbles act as radio-enhancer for treatment of large-scale prostate tumours in vivo
EF 2023-24
Résumé
The project aims to expand on previous animal studies that were conducted mainly on mice models, by examining the impact of ultrasound-stimulated microbubbles (USMB) and radiation therapy (XRT) in larger animal models, such as rabbits. Rabbits have larger, more diverse tumour tissues than those observed in mice models, which are more like the tumours seen in human patients. The goal is to observe how the larger, more diverse tumours respond to combination treatment (USMB+XRT) to assess whether it could be effective for cancer treatment in human patients in the clinic. Microbubbles (MB) are small, microscopic gas bubbles encased in a protective shell that can circulate in the bloodstream. Once injected into veinous circulation, ultrasound (US) waves will be targeted at the tumour only, which will activate the MB around the tumour area only, reducing damage to healthy, non-cancerous tissues surrounding the tumour. The US activates the MB by exciting them enough to rupture, which causes damage to the blood vessels the MB are sitting in. The damage caused by MB rupture temporarily weakens the tumour, making it more susceptible to XRT. When used alone, XRT causes cell death, but if the tumour is weaker from MB activation, the amount of cancer cell death is significantly increased. USMB can be used to enhance the effects of XRT when used together, which has the potential to reduce the dose of radiation needed to achieve effective cancer cell death. If lower-dose radiation can be used to treat patients, they are less likely to experience adverse side effects from high-dose radiation or radiation toxicity during their treatments. The more effective the treatment is at removing the cancer cells, the less likely the tumours are to grow back or spread to surrounding areas.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
506236
Name
Petchiny Tera
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Acoustically-stimulated microbubbles act as radio-enhancer for treatment of large-scale prostate tumours in vivo
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer; Cancer Treatment; Histopathology; Immunohistochemistry; Microbubbles; Pre-Clinical Model; Radiation; Ultrasound
Abstract
The project aims to expand on previous animal studies that were conducted mainly on mice models, by examining the impact of ultrasound-stimulated microbubbles (USMB) and radiation therapy (XRT) in larger animal models, such as rabbits. Rabbits have larger, more diverse tumour tissues than those observed in mice models, which are more like the tumours seen in human patients. The goal is to observe how the larger, more diverse tumours respond to combination treatment (USMB+XRT) to assess whether it could be effective for cancer treatment in human patients in the clinic. Microbubbles (MB) are small, microscopic gas bubbles encased in a protective shell that can circulate in the bloodstream. Once injected into veinous circulation, ultrasound (US) waves will be targeted at the tumour only, which will activate the MB around the tumour area only, reducing damage to healthy, non-cancerous tissues surrounding the tumour. The US activates the MB by exciting them enough to rupture, which causes damage to the blood vessels the MB are sitting in. The damage caused by MB rupture temporarily weakens the tumour, making it more susceptible to XRT. When used alone, XRT causes cell death, but if the tumour is weaker from MB activation, the amount of cancer cell death is significantly increased. USMB can be used to enhance the effects of XRT when used together, which has the potential to reduce the dose of radiation needed to achieve effective cancer cell death. If lower-dose radiation can be used to treat patients, they are less likely to experience adverse side effects from high-dose radiation or radiation toxicity during their treatments. The more effective the treatment is at removing the cancer cells, the less likely the tumours are to grow back or spread to surrounding areas.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Petchiny, Tera
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~